Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc."
Results 41 - 60
of 289
Sorted by Relevance
|
Sort by Date
7 Jun 2019, 7:39 am
Merrell Dow Pharmaceuticals, Inc.[2], the Court ruled that Rule 702 of the Federal Rules of Evidence did not incorporate the Frye general acceptance test as a basis for assessing scientific testimony. [read post]
7 Jun 2019, 7:39 am
Merrell Dow Pharmaceuticals, Inc.[2], the Court ruled that Rule 702 of the Federal Rules of Evidence did not incorporate the Frye general acceptance test as a basis for assessing scientific testimony. [read post]
19 Mar 2018, 2:50 pm
Merrell Dow Pharmaceuticals, Inc. [read post]
30 May 2017, 10:10 am
Merrell Dow Pharmaceuticals Inc. [read post]
30 Jan 2011, 5:29 pm
Merrell Dow Pharms., Inc., 43 F.3d 1311, 1315 (9th Cir.1995) (“ Daubert II ”). [read post]
5 Jan 2019, 12:15 pm
Merrell Dow Pharmaceuticals, Inc., U.S. [read post]
8 Feb 2011, 11:47 am
Merrill Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
28 Jul 2011, 11:19 am
He didn't file suit, however, until June 2009.Dead to rights under the Texas two-year statute of limitations, plaintiff tried to argue that his claim didn't "accrue" until there was scientific evidence sufficient to satisfy Texas' version of Daubert, which was imposed in Merrell Dow Pharmaceuticals, Inc. v. [read post]
11 Oct 2018, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), an increasing number of expert witnesses have been challenged by way of a Daubert motion. [read post]
18 Dec 2009, 11:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
31 Oct 2016, 10:40 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
31 Oct 2016, 10:40 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
7 Mar 2016, 8:51 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), that is relevant in determining the admissibility of such testimony. [read post]
9 Mar 2009, 7:31 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993). [read post]
13 Mar 2018, 6:00 am
Fleetwood Homes of Pennsylvania, Inc., 878 A.2d 509 (Me. 2005) although more Daubert than Frye. [read post]
29 Jun 2020, 12:41 pm
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993), and the testimony is helpful to the trier of fact to understand the evidence through specialized, scientific, or technical expertise. [read post]
13 Feb 2018, 6:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
18 Jun 2019, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which focuses on an analysis of enumerated factors when determining expert admissibility. [read post]
2 Jul 2019, 8:40 am
Merrell Dow Pharmaceuticals, Inc. [read post]
2 Jul 2019, 8:40 am
Merrell Dow Pharmaceuticals, Inc. [read post]
